For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory diseases caused by equine herpes virus type I (EHV-!) and type 4 (EHV-4), and by equine influenza virus types A2 North American and A2 Eurasian. Inoculate horses intramuscularly with a 2ml dose. Administer a second 2 ml dose intramuscularly in 3-4 weeks using a different injection site. Administer a third 2 ml dose in 3-4 weeks by either intramuscular injection or intranasal route. Revaccinate annually.
Dosage: Using aseptic technique inoculate
horses IM with a 2 mL dose. Administer
a second 2 mL dose IM in 3-4
weeks using a different injection site.
Administer a third 2 mL dose in 3-4
weeks either IM or IN. Revaccinate
annually and prior to anticipated
exposure either IM or IN.
Precautions: Store at a temperature between
35° - 45° F (2° - 7° C). Protect
from freezing. Shake well before
using. Do not vaccinate within
21 days of slaughter.